Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Documentation for glioma susceptibility 1 is limited primarily due to the rarity of the condition and the complexity of its genetic basis. As it affects a relatively small population, systematic clinical studies have been scarce. Additionally, the multifactorial nature of the disease complicates the identification of clear clinical features, making it difficult to establish a comprehensive understanding of its presentation.
To navigate glioma susceptibility 1, consider consulting a neuro-oncologist who specializes in brain tumors and hereditary cancer syndromes. Genetic counseling may also be beneficial, especially for family planning and understanding the implications of the ERBB2 gene variant. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Additionally, participating in research studies or registries may provide valuable insights into your condition.
There are several orphan drugs designated for glioma susceptibility 1, including (-)-B-Elemene and various other agents currently in development. While specific clinical trials are not available at this time, ongoing research may lead to new treatment options in the future. For updates on clinical trials, you can search ClinicalTrials.gov for glioma-related studies.
Actionable guidance for navigating care for glioma susceptibility 1
To navigate glioma susceptibility 1, consider consulting a neuro-oncologist who specializes in brain tumors and hereditary cancer syndromes. Genetic counseling may also be beneficial, especially for family planning and understanding the implications of the ERBB2 gene variant. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Additionally, participating in research studies or registries may provide valuable insights into your condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
AXIUM Pharmaceuticals, Inc.
Other
AbbVie Inc.
Other
Accendatech USA Incorporated
Other
Accord Healthcare Inc.
Other
Advanced Imaging Projects, LLC
Other
Angiochem, Inc.
Other
Apogenix GmbH
Other
Bayer HealthCare Pharmaceuticals Inc.
Other
Benuvia Therapeutics, LLC
Other
Bexion Pharmaceuticals, Inc
Other
CTI BioPharma Corporation
Other
Cantex Pharmaceuticals
Other
Cavion, LLC
Other
CyGenica Ltd.
Other
CytoVac A/S
Other
Deciphera Pharmaceuticals, LLC
Other
Denovo Biopharma LLC
Other
Diffusion Pharmaceuticals, LLC
Other
DualTpharma B.,V.
Other
EpicentRx, Inc.
Other
Ethypharm SA
Other
Gan & Lee Pharmaceuticals USA Corporation
Other
Gemini Therapeutics, Inc.
Other
Genenta Sciences
Other
Lentigen Corporation
Other
Moleculin Biotech, Inc.
Other
Musli Thyropeutics Ltd.
Other
Myrexis, Inc.
Other
NanoPharmaceuticals, LLC
Other
NeoImmuneTech, Inc.
Other
Neutron Technology Corp.& Neutron R&D Partner
Other
Novartis Pharmaceuticals Corporation
Other
Oblato, Inc.
Other
Peregrine Pharmaceuticals, Inc.
Other
Rgenix, Inc.
Other
SK Life Science, Inc.
Other
Sichuan Honghe Biotechnology Co., Ltd.
Other
Soligenix, Inc.
Other
Stemgen Spa
Other
Theragnostics Inc
Other